XRAY:NSD-Dentsply Sirona Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 12.82

Change

-0.01 (-0.08)%

Market Cap

USD 2.70B

Volume

2.61M

Analyst Target

USD 48.77
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. Its Essential Dental Solutions segment offers motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. Its Wellspect Healthcare segment offers intermittent urinary catheters under the LoFric brand and irrigation systems under the Navina brand. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ISRG Intuitive Surgical Inc

-14.42 (-2.99%)

USD 161.79B
COO The Cooper Companies, Inc

-0.81 (-1.02%)

USD 15.49B
HOLX Hologic Inc

-0.62 (-1.08%)

USD 13.84B
ALGN Align Technology Inc

+0.81 (+0.47%)

USD 11.30B
RGEN Repligen Corporation

+1.64 (+1.26%)

USD 7.49B
MMSI Merit Medical Systems Inc

-1.29 (-1.42%)

USD 6.12B
ICUI ICU Medical Inc

-1.95 (-1.41%)

USD 3.43B
LMAT LeMaitre Vascular Inc

-1.56 (-1.81%)

USD 1.93B
ATRC AtriCure Inc

-0.27 (-0.84%)

USD 1.70B
AZTA Azenta Inc

-0.22 (-0.87%)

USD 1.43B

ETFs Containing XRAY

HBD:CA BetaPro Gold Bullion 2x D.. 6.53 % 1.52 %

N/A

CAD 2.36M
HND:CA BetaPro Natural Gas 2x Da.. 6.04 % 1.52 %

+0.81 (+0%)

CAD 0.19B
MVUS:SW 3.32 % 0.00 %

N/A

N/A
SPMV:SW 3.32 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -32.46% 33% F 27% F
Dividend Return 0.84% 100% F 54% F
Total Return -31.61% 35% F 28% F
Trailing 12 Months  
Capital Gain -57.79% 24% F 18% F
Dividend Return 1.58% 75% C 35% F
Total Return -56.21% 24% F 18% F
Trailing 5 Years  
Capital Gain -67.88% 26% F 20% F
Dividend Return 6.09% 50% F 13% F
Total Return -61.79% 26% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain -13.40% 24% F 19% F
Dividend Return -12.27% 24% F 20% F
Total Return 1.13% 60% D- 29% F
Risk Return Profile  
Volatility (Standard Deviation) 30.28% 76% C+ 59% D-
Risk Adjusted Return -40.52% 24% F 18% F
Market Capitalization 2.70B 82% B 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector